Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: A randomized, double-blinded, exploratory study with vortioxetine.

•We investigated the treatment of residual cognitive symptoms in remitted depression.•Remitted patients improved, with no statistically significant treatment differences.•Secondary results indicate numerical benefits of vortioxetine across symptom domains.